LATEST NEWS

The Victor Phillip Dahdaleh Heart and Lung Research Institute (HLRI) is home to the largest concentration of scientists and clinicians in heart and lung medicine in Europe. The Institute is a joint venture between Cambridge University and Royal Papworth Hospital and represents a major expansion of cardiovascular and respiratory research capacity. It has the ambitious goal of identifying […]

23/05/2023

McGill University recently published an interview with Victor Dahdaleh about his C$30million of philanthropic support to establish a new institute to help transform genomic medicine. Read more here about Victor’s motivations and aspirations for the new Victor Phillip Dahdaleh Institute of Genomic Medicine.  Read more here: https://giving.mcgill.ca/all-stories/future-medicine-mcgills-new-genomic-medicine-institute-promises-transform-healthcare

19/01/2023

A landmark donation to support McGill University’s renowned genomics research and education programs from UK-based alumnus and long-time donor Victor Dahdaleh will be a catalyst for advancements in genomics research. Thanks to gifts from Mr. Dahdaleh totalling more than $30 million, McGill will launch the Victor Phillip Dahdaleh Institute of Genomic Medicine. For more details see […]

25/10/2022

Introduction to the Gift The gift will support upgrades to the Victor Phillip Dahdaleh Building on York University’s Keele Campus, provide operating funding to CIFAL York, and support a new operations facility for the Advanced Disaster, Emergency and Rapid Response Simulation initiative. York was honoured to welcome alumnus and philanthropist Victor Dahdaleh and his wife […]

25/10/2022

Mesothelioma is an aggressive cancer usually caused by breathing in asbestos dust. Most of the cases affect people’s lungs but it can strike in other parts of the body.  With only 7% of those diagnosed surviving more than 5 years, the condition tragically causes 2,394 deaths a year in the UK.   As the UK’s leading […]

04/07/2022

Delighted to see the MiST 1 mesothelioma research paper, partly funded by the Victor Dahdaleh Foundation, published in The Lancet. It’s encouraging to witness positive news in this specialist research area and the benefits of innovative trial approaches. Full details of the Paper can be found here.

01/02/2021

Victor and Mona Dahdaleh were delighted to attend a recent Canadian Centennial Scholarship Fund (CCSF) online reception to celebrate the success of CCSF Scholarship recipients. The two latest Victor Dahdaleh Foundation Scholars for the 2020/21 academic year, Rebecca Clark (studying for a PhD in Infectious Disease Epidemiology at the London School of Hygiene and Tropical […]

21/12/2020

LONDON, Dec. 2, 2020 — Researchers at York University’s Dahdaleh Institute for Global Health Research, in partnership with Médecins sans Frontières (MSF/Doctors Without Borders), have launched the Safe Water Optimization Tool (SWOT). This web-based platform represents the first concrete use of artificial intelligence to improve safe water access in humanitarian settings. A Groundbreaking Solution for […]

02/12/2020

The Victor Dahdaleh Foundation is delighted to be supporting a programme led by researchers at the Universities of Cambridge and Leeds into tackling the asbestos based cancer – mesothelioma. According to the researchers, gold nanotubes, tiny hollow cylinders one thousandth the width of a human hair, could be used to treat mesothelioma, a type of […]

27/10/2020